Loading song details...
Decoding DDX41 Clinical Impact Of Germline And Somatic Mutations In High Risk Myeloid Neoplasms
No description available.
MP3 Download
Video Download
Related Songs
3:06
Decoding DDX41 Clinical Impact Of Germline And Somatic Mutations In High Risk Myeloid Neoplasms
5:48
What Is The Clinical Impact Of DDX41 Mutations In Myeloid Neoplasms
1:28
DDX41 And Its Unique Contribution To Myeloid Leukemogenesis Oncotarget
2:12
Predicting DDX41 Mutant MDS Outcomes Needs A Risk Scoring System Carmelo Gurnari MD ASH 2023
1:00:48
Germline And Somatic Defects In DDX41 Its Impact On Myeloid Neoplasms
2:09
Outcomes Of Patients With IDH1 2 Mutated Accelerated Blast Phase MPNs In The Era IDH Inhibitors
1:33
Quantifying Mutant MYD88 Expression To Track Disease Burden In WM
1:06:42
Pulling The Molecular Thread Through Pediatric Thrombocytopenia MDS And AML
2:19:30
Hereditary Hematologic Malignancies Not That Rare Dr Courtney DiNardo
55:38
11 07 19 Five Points Teresa Bowman
1:19:29
MDSR 2024 Germline Predisposition
20:21
Deep Dive Into Targeted Therapies Understanding IDH1 Mutant AML Treatments
1:02:01
Integrative Clinical Management Of HEDS And Its Common Comorbidities Dr Brayden Yellman MD
33:58
USD497 Special Breakdown Plus Medical Evaluation
2:51
AML Mutant IDH1 Inhibitor HMS 101
0:50
Update On The PIMMs Trial Of Ivosidenib For Patients With IDH1 Mutated CCUS
2:16
The Combination Of Olutasidenib And Azacitidine In IDH1 Mutated AML
5:18
Phase I II Study Of Decitabine Venetoclax And Ivosidenib Or Enasidenib In IDH Mutated AML
1:55
Early Intervention With IDH Inhibitors In Mutated MDS Insights From Clinical Experience
17:07